Cooke & Bieler LP Boosts Stock Position in Integer Holdings Corporation (NYSE:ITGR)

Cooke & Bieler LP boosted its holdings in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 6.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 317,393 shares of the medical equipment provider's stock after purchasing an additional 18,790 shares during the period. Cooke & Bieler LP owned about 0.91% of Integer worth $37,456,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of ITGR. Proficio Capital Partners LLC purchased a new position in Integer in the fourth quarter worth $2,195,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Integer by 3.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,904 shares of the medical equipment provider's stock valued at $782,000 after buying an additional 180 shares during the period. HighTower Advisors LLC raised its stake in shares of Integer by 1.4% in the fourth quarter. HighTower Advisors LLC now owns 12,207 shares of the medical equipment provider's stock valued at $1,618,000 after buying an additional 166 shares during the period. Swiss National Bank raised its stake in shares of Integer by 0.8% in the fourth quarter. Swiss National Bank now owns 65,900 shares of the medical equipment provider's stock valued at $8,733,000 after buying an additional 500 shares during the period. Finally, Royce & Associates LP raised its stake in shares of Integer by 31.9% in the fourth quarter. Royce & Associates LP now owns 61,759 shares of the medical equipment provider's stock valued at $8,184,000 after buying an additional 14,919 shares during the period. Hedge funds and other institutional investors own 99.29% of the company's stock.

Insider Buying and Selling

In other news, Director Martin C. Maxwell sold 8,720 shares of the company's stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the completion of the transaction, the director directly owned 22,170 shares in the company, valued at approximately $2,672,815.20. This represents a 28.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Joseph W. Dziedzic sold 338,975 shares of the company's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer owned 47,000 shares of the company's stock, valued at $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock worth $44,577,115 over the last ninety days. 2.16% of the stock is owned by corporate insiders.

Integer Price Performance

Integer stock traded down $2.36 during midday trading on Thursday, hitting $114.77. 554,711 shares of the company's stock were exchanged, compared to its average volume of 389,836. Integer Holdings Corporation has a 52-week low of $104.93 and a 52-week high of $146.36. The stock has a 50-day moving average price of $119.86 and a two-hundred day moving average price of $124.72. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40. The company has a market cap of $4.00 billion, a P/E ratio of 54.39, a PEG ratio of 1.01 and a beta of 0.98.

Integer (NYSE:ITGR - Get Free Report) last posted its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.95% and a net margin of 4.38%. The business had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. During the same period in the previous year, the business earned $1.14 earnings per share. The firm's revenue was up 7.3% on a year-over-year basis. On average, equities research analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ITGR. Raymond James Financial boosted their target price on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. Truist Financial set a $150.00 target price on Integer and gave the company a "buy" rating in a research note on Friday, April 25th. Benchmark lowered their target price on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. KeyCorp lowered their target price on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Finally, Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and boosted their price objective for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $146.25.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.